MapLight Therapeutics (MPLT) Other Working Capital Changes (2024 - 2025)

MapLight Therapeutics (MPLT) posted Other Working Capital Changes of -$204000.0 for Q4 2025, down 15.91% sequentially from -$176000.0 in Q4 2024, and down 15.91% YoY from -$242594.6 in Q4 2024.

MapLight Therapeutics (MPLT) Other Working Capital Changes (2024 - 2025) Analysis & Trends

MapLight Therapeutics has reported Other Working Capital Changes for 2 years, with the latest figure at -$204000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 MapLight Therapeutics 533.88 Mn 533.88 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -204,000.00
Dec 31, 2025 -204,000.00
Dec 31, 2025 -204,000.00
Dec 31, 2024 -176,000.00
Dec 31, 2024 -176,000.00
Dec 31, 2024 -176,000.00